POS-753 LONG TERM BENEFITS OF PRESERVED GRAFT FUNCTIONS AFTER LATE WITHDRAWAL OF CALCINEURIN INHIBITORS IN LIVE DONOR KIDNEY TRANSPLANT RECIPIENTS.
G. Narayen, A. Raman, S.L. Gowrishanker and 1 more
Kidney International Reports · 2021
doi:10.1016/j.ekir.2021.03.785 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
With the use of calcineurin inhibitors (CNI) and induction therapy , graft survival has reached over 90% at 1 year. Despite short and medium term improvement , long term graft survival has not shown proportionate improvement. There is debate about role of CNI induced nephrotoxicity and long term graft dysfunction and there is no uniformity in renal outcome after CNI minimization or withdrawal 1 year after transplantation, especially in live donor transplants and well matched kidneys. This retrospective data analyses the long term outcome of patient and graft survival after CNI withdrawal from triple drug therapy of CNI, prednisolone and azathioprine /mycophenolate mofetyl (MMF)
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.